April 22, 2025 - CAT V Biotech, Inc

After eliminating debt, cutting dilution, and driving revenue, Opus launches a bold incubation strategy—targeting 3–5 spin-offs in 24 months to maximize shareholder value Miami, FL – April 22, 2025 – Opus Holdings, Inc. (OTC: CATV), pending name and ticker change to Opus Holdings, Inc. (OTC: OPHD), proudly announces the official appointment of two other individuals in our leadership team. Following the strategic appointment of CEO Susan Ward, the Company now solidifies a seasoned, cross-functional leadership group to steer its transformation into a premier business incubator for emerging companies across biotech, wellness, tech, and consumer goods. Joining Ward at the helm are: Israel Mirsky – Senior Advisor A two-time founder and recognized technology strategist, Israel Mirsky has advised global organizations in the fields of ad tech, medicine, and data innovation. He previously led the technology arm of OMD Worldwide, driving campaigns that earned back-to-back Adweek Agency of the Year awards. His leadership at Annalect resulted in scalable tech products for Fortune 100 brands, while his sustainability work with the Rainwater Alliance exemplifies his commitment to tech-driven solutions. Mirsky also ran Intel’s global media business at Omnicom, showcasing deep experience in integrated marketing, infrastructure development, and digital acceleration—critical pillars for Opus Holdings’ future spin-offs. Natacha St. Louis – Business DevelopmentNatacha St. Louis has over 20 years of experience in economic development, compliance, and operations across both private and public sectors. She began her career at American Express before advancing to leadership in the Executive Office. St. Louis later brought her strategic insights into public service with the City of Sunrise and the Broward County School District, where she developed programs to increase minority business participation. As a tax expert, consultant, and IRS-enrolled agent, she has reduced liabilities for countless businesses. Holding advanced degrees and certifications from Nova Southeastern University, Cornell, and USF, she brings regulatory, operational, and people-focused leadership that will help streamline the launch and scale of Opus portfolio companies. Together, this team brings over 65 years of combined experience, responsible for scaling startups, guiding public market entries, managing initiatives exceeding $400 million, and executing sustainable innovation for global brands. “We’re building more than a leadership team—we’re building a platform,” said Susan Ward, CEO. “Each executive brings an elite track record and the operational rigor to unlock exponential value for our shareholders and portfolio companies alike.” Operational Momentum Backed by Results As outlined in the Company’s recently released Annual Report, Opus achieved nearly $500K in Q4 revenue, eliminated $830K in debt, and reduced over 8 billion dilutive shares. Q1 2025 sales have remained steady, and the financial trajectory supports a robust incubation strategy for current and incoming subsidiaries. A Disciplined Vision for 2025 and Beyond Under this new leadership structure, Opus Holdings will: Accelerate acquisitions in growth sectors via a refined sourcing pipeline Incubate and transition companies through IPOs or public mergers The Opus platform is now operational, and discussions are already underway with several high-potential private companies. The goal: to complete 3-5 spin-offs within the next 24 months, each structured to deliver direct shareholder benefit. “We are laser-focused on deal flow, structure, and sustainability,” added Israel Mirsky. “Our model isn’t theory—it’s backed by execution. We’re ready.” About Opus HoldingsOpus Holdings, Inc. is a U.S.-based business incubator focused on acquiring, developing, and transitioning private companies into the public markets. Through operational support, strategic growth frameworks, and spin-off execution, Opus drives long-term shareholder value.

$24B

2021 Global CBD Retail Sales

16%

in beverage

20%

in Capsules

40%

in Oils and Edibles

The Industry

Opus Holdings Unveils Powerhouse Leadership Team to Drive Aggressive Growth and Transform Market Trajectory

About us

Categories